Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 4, 2026

A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
08:22

A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene

Published on: September 16, 2019

A highly sensitive genetic protocol to detect NF1 mutations.

María Carmen Valero1, Yolanda Martín, Elisabete Hernández-Imaz

  • 1Molecular Genetics Unit, University Hospital Ramón y Cajal, Institute of Health Research, IRYCIS, Madrid, Spain.

The Journal of Molecular Diagnostics : JMD
|March 1, 2011
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the ALIBIRD mHealth Platform for Care of Patients With Lung Cancer: Prospective Pilot Study.

JMIR cancer·2026
Same author

Analysis of Posttraumatic Stress Disorder Gene Expression Profiles in a Prospective, Community-Based Cohort.

Human biology·2024
Same author

Successful Pregnancy and Cancer Outcomes With Ipilimumab and Nivolumab for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2022
Same author

Neurofibromatosis type 1 families with first-degree relatives harbouring distinct <i>NF1</i> pathogenic variants. Genetic counselling and familial diagnosis: what should be offered?

Journal of medical genetics·2022
Same author

National protocol led to significant improvements in follow-up programmes for very low birth weight or very preterm infants.

Acta paediatrica (Oslo, Norway : 1992)·2021
Same author

Methylation of the Sclerostin <i>(SOST)</i> Gene in Serum Free DNA: A New Bone Biomarker?

Genetic testing and molecular biomarkers·2020

Detecting neurofibromatosis type 1 (NF1) mutations is challenging. A new combined RNA and DNA method achieves 95% sensitivity in identifying NF1 germline mutations, improving molecular diagnosis.

Area of Science:

  • Genetics
  • Molecular Biology
  • Medical Diagnostics

Background:

  • Neurofibromatosis type 1 (NF1) is an inherited disorder caused by mutations in the NF1 gene.
  • Detecting NF1 mutations is difficult due to the gene's large size, lack of hotspots, pseudogenes, and diverse lesion types.

Purpose of the Study:

  • To develop and validate a sensitive method for detecting germline mutations in the NF1 gene.
  • To provide a comprehensive spectrum of NF1 mutations for improved molecular diagnosis.

Main Methods:

  • Combined RNA-based cDNA-PCR mutation detection with denaturing high-performance liquid chromatography (DHPLC) and multiplex ligation-dependent probe amplification (MLPA).
  • Validated the protocol on 56 NF1 patient blood samples, subsequently applied to 105 patients.

More Related Videos

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors
05:46

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors

Published on: June 27, 2025

Related Experiment Videos

Last Updated: Jun 4, 2026

A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
08:22

A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene

Published on: September 16, 2019

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors
05:46

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors

Published on: June 27, 2025

Main Results:

  • Achieved 95% sensitivity in identifying germline mutations in 53 out of 56 validated NF1 cases.
  • Successfully detected various mutation types: single-base substitutions, small deletions/insertions, microdeletions, and copy number variations.
  • Analysis provided insights into mutation nature and effects on NF1 mRNA splicing.

Conclusions:

  • The developed protocol is a powerful and reliable tool for the molecular diagnosis of NF1.
  • Implementation as a routine test facilitates efficient identification of the NF1 mutation spectrum.